-
Published31/03/2025
-
Deadline28/04/2025
-
Today28/04/2025
-
Opening of tenders29/04/2025
Utilities
- indicates CPV codes deduced from the text of the procedure
- indicates text translated automatically in your browsing language
‘Supply of anti-tumor medicinal products for the needs of Sveti Mina EOOD, Blagoevgrad – second part’, by lot Text automatically translated in your browsing language Automatically translated
The subject of the public procurement procedure was ‘Supply of anti-tumor medicinal products for the needs of Sveti Mina EOOD, Blagoevgrad, Part Two’ under lots, divided into 6 (six) lots, as follows: Lot 1 - Niraparib, abiraterone 50 mg/500 mg; Lot 2 – Niraparib, abiraterone 100 mg/500 mg; Lot 3 - Nivolumab,Relatlimab; Lot 4 - Atezolizumab; Lot 5 – Nintedanib 150 mg; Lot 6 – Nintedanib 100 mg. The technical requirements of the Contracting Authority for medicinal products are detailed in the Technical Specification - Annex No 1. Text automatically translated in your browsing language Automatically translated
https://app.eop.bg/today/474434
https://app.eop.bg/today/474434
33600000 - Pharmaceutical products
33690000 - Various medicinal products CVP code deduced from the text of the procedure AI-generated
This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.